Evidence map›Paper›PMID 41070608›Full record

ReviewMolecular medicine reports2025

Multifaceted functions of Y‑box binding protein 1 in RNA methylated modifications (Review).

Guofeng Xie, Yongping Xie, Xichao Xu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Molecular medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Guofeng XieDepartment of Pharmacy, Chengdu Seventh People's Hospital (Affiliated Cancer Hospital of Chengdu Medical College), Chengdu, Sichuan 610213, P.R. China.
Yongping XieDepartment of Pharmacy, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong 518100, P.R. China.
Xichao XuEndoscopy Center and Gastroenterology Department, Key Laboratory for Precision Diagnosis and Treatment of Pediatric Digestive System Diseases, Shenzhen Children's Hospital, Shenzhen, Guangdong 518036, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Y‑box binding protein 1 (YBX1/YB‑1) is a DNA/RNA‑binding protein, which plays a crucial role in promoting tumor progression and resistance to anticancer drugs. YBX1 is widely involved in a range of biological processes such as DNA repair, mRNA transcription, pre-mRNA splicing, mRNA stability regulation, translation and exosome sorting. In addition to these canonical DNA/RNA‑binding protein functions, YBX1 can also have a regulatory role in N6‑methyladenine (m

Indexed as

RNARNA Processing, Post-TranscriptionalY-Box-Binding Protein 1AnimalsDrug Resistance, NeoplasmHumansMethylationNeoplasmsRNA, MessengerRNARNA, MessengerY-Box-Binding Protein 1YBX1 protein, humandrug resistancem5C modificationm6A modificationSU056Y‑box binding protein 1

Identifiers

PMID41070608
PMCPMC12529089

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.